vimarsana.com

Page 354 - Advanced Cellular Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Seres s Bacteria in a Pill Becomes First FDA-Approved Oral Microbiome Therapy

Recurrent Clostridioides difficile infection can be treated with fecal microbiota transplants. FDA approval of Seres Therapeutics’ Vowst makes it the first oral microbiome therapy.

In Which Areas of Healthcare Do Investors Want More Startup Activity?

While the digital health sector might feel a little cramped in some areas, there are wide open spaces in others and investors are ready to funnel money into companies looking to innovate these lesser-discussed aspects of care delivery and healthcare technology. Some of these areas include Medicaid, generative AI and patient-to-patient support.

Startup Aims To Bring Culturally Competent Care to Neurodivergent Adults Through Partnership

Through a new partnership, Hopper Health’s providers and peer navigators will receive a personalized training plan from Violet that will help the clinicians and navigators understand how to provide inclusive care for patients of color and LGBTQ+ communities. It will teach topics including anti-racism, allyship, social determinants of health, trauma-informed care and other areas.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.